The U.S. Food and Drug Administration has approved an oral solution that combines the anti-inflammatory Cambia plus potassium bicarbonate for the treatment of migraine. In recent studies, the drug was found to be effective in treating migraine as well as migraine complications such as photophobia, phonophobia, and nausea. Experts say it helped patients in as little as fifteen minutes after the onset of symptoms.
Read moreFull Question: I get a precursor to a migraine if it is going to be a severe one. The weather has made a dramatic change today, and I... Read more »
The FDA has approved a new prescription medication for the acute treatment of Migraine attacks, Cambia, developed by Kowa Pharmaceuticals... Read more »
Do you have questions about headaches or Migraines? Many of our readers do, and each week, and Dr. John Claude Krusz and Teri Robert answer... Read more »
Full Question: What My daughter is 30 and has suffered with migraines for about 2 years now and sometimes they come and last for days.... Read more »
The Food and Drug Administration (FDA) recently issued safety announcement for Celexa (citalopram hydrobromide), an antidepressant... Read more »
Everything Migraine and Headache Here is a master list of our content listed in alphabetical order. You can search the page by hitting the control... Read more »
Researchers have identified a gene mutation that could impact triggering Migraines and provide a direction for developing new treatments. Using... Read more »
Informative and Educational Migraine and Headache Articles These articles are listed in alphabetical order. You can search the page by hitting the... Read more »
How to best taper up to therapeutic dosage Topamax (topiramate) is a medication originally developed for seizure control. It is also FDA approved... Read more »
It is a good idea to type and print your migraine diary before you see your doctor in order to keep it legible and clean. If you arrive prepared,... Read more »